Publication: RISK OF DEVELOPING SUBCLINICAL HYPOTHYROIDISM AMONG INDIVIDUALS WITH TSH VALUES 2.5-4.2 mIU/L
| dc.contributor.authors | Cevlik, Tulay; Haklar, Goncagul; Sirikci, Onder; Emerk, Kaya | |
| dc.date.accessioned | 2022-03-12T20:27:08Z | |
| dc.date.accessioned | 2026-01-11T06:26:02Z | |
| dc.date.available | 2022-03-12T20:27:08Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Objective: Estimating the serum thyroid stimulating hormone (TSH) concentration is the most sensitive test to show thyroid function. TSH values of 95 percent of the population fall between 0.3-2.5 mIU/L. Although lower limits of the reference interval is certain, upper limits remains controversial. Research data indicate that individuals with TSH values outside the 2.5-3.0 mIU/L interval are under risk for thyroid disorders. The purpose of this study is to investigate the time dependent subclinical hypothyroidism risk of the individuals with TSH values over 2.5 mIU/L. Material and Method: The research is composed of three groups including healthy subjects with TSH values between 0.27-2.5 mIU/L (n=55) with negative thyroid peroxidase antibody (TPO Ab) and thyroglobulin antibody (TG Ab) values and cases with TSH values between 2.5-4.2 mIU/L and with positive (60) and negative (n=212) anti-TPO and anti-TG levels. The data are surveyed retrospectively and the difference between the past and present TSH levels are investigated. For statistical analysis paired and unpaired t-test is used. Results: In all groups statistically meaningful elevation of time dependent TSH values were found. While in the group with TSH values between 2.5-4.2 mIU/L and negative thyroid antibodies the risk of subclinical hypothyroidism was calculated as 23% for the first 5 years, for the group with positive antibodies it was found to be 30%. TSH values 0.27-2.5 mIU/L no subclinical hypothyroidism was evident in 5 years of duration. Conclusion: The results showed that individuals with TSH values between 2.5-4.2 mIU/L are under risk for subclinical hypothyroid independent of thyroid antibody concentration. | |
| dc.identifier.doi | doiWOS:000384737100003 | |
| dc.identifier.issn | 1305-2381 | |
| dc.identifier.uri | https://hdl.handle.net/11424/233628 | |
| dc.identifier.wos | WOS:000384737100003 | |
| dc.language.iso | tur | |
| dc.publisher | NOBEL ILAC | |
| dc.relation.ispartof | NOBEL MEDICUS | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Subclinical hypothyroidism | |
| dc.subject | TSH reference interval | |
| dc.subject | TPO Ab | |
| dc.subject | TG Ab | |
| dc.subject | THYROTROPIN REFERENCE RANGE | |
| dc.subject | THYROID-DISEASE | |
| dc.subject | REFERENCE INTERVALS | |
| dc.subject | FOLLOW-UP | |
| dc.subject | ULTRASONOGRAPHY | |
| dc.subject | ASSOCIATION | |
| dc.subject | DYSFUNCTION | |
| dc.subject | POPULATION | |
| dc.subject | ANTIBODIES | |
| dc.subject | COMMUNITY | |
| dc.title | RISK OF DEVELOPING SUBCLINICAL HYPOTHYROIDISM AMONG INDIVIDUALS WITH TSH VALUES 2.5-4.2 mIU/L | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 25 | |
| oaire.citation.issue | 2 | |
| oaire.citation.startPage | 20 | |
| oaire.citation.title | NOBEL MEDICUS | |
| oaire.citation.volume | 12 |
